المؤلفون: Dias MH; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Friskes A; Division of Cell Biology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Wang S; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Fernandes Neto JM; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., van Gemert F; Division of Tumor Biology and Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Mourragui S; Hubrecht Institute-KNAW (Royal Netherlands Academy of Arts and Sciences) and University Medical Center, Utrecht, the Netherlands., Papagianni C; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Kuiken HJ; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Mainardi S; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Alvarez-Villanueva D; Chemoresistance and Predictive Factors Group, Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology (ICO), Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet del Llobregat, Barcelona, Spain., Lieftink C; Division of Molecular Carcinogenesis, NKI Robotic and Screening Center, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Morris B; Division of Molecular Carcinogenesis, NKI Robotic and Screening Center, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Dekker A; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., van Dijk E; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Wilms LHS; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., da Silva MS; Department of Biochemistry, Institute of Chemistry, University of São Paulo, São Paulo, SP, Brazil.; Department of Chemical and Biological Sciences, Institute of Biosciences, São Paulo State University (UNESP), Botucatu, SP, Brazil., Jansen RA; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Mulero-Sánchez A; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Malzer E; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Vidal A; Department of Pathology, University Hospital of Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.; Xenopat S.L., Parc Cientific de Barcelona (PCB), Barcelona, Spain., Santos C; Department of Medical Oncology, Catalan Institute of Oncology (ICO), Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), CIBERONC, Barcelona, Spain., Salazar R; Department of Medical Oncology, Catalan Institute of Oncology (ICO), Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), CIBERONC, Barcelona, Spain., Wailemann RAM; Center of Toxins, Immune-response and Cell Signaling, Instituto Butantan, São Paulo, Brazil., Torres TEP; Center of Toxins, Immune-response and Cell Signaling, Instituto Butantan, São Paulo, Brazil.; Department of Clinical and Experimental Oncology, Federal University of São Paulo (UNIFESP), São Paulo, Brazil., De Conti G; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Raaijmakers JA; Division of Cell Biology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Snaebjornsson P; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; University of Iceland, Faculty of Medicine, Reykjavik, Iceland., Yuan S; The Third Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Shanghai, China., Qin W; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Kovach JS; Lixte Biotechnology Holdings, Inc., Pasadena, California., Armelin HA; Center of Toxins, Immune-response and Cell Signaling, Instituto Butantan, São Paulo, Brazil., Te Riele H; Division of Tumor Biology and Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., van Oudenaarden A; Hubrecht Institute-KNAW (Royal Netherlands Academy of Arts and Sciences) and University Medical Center, Utrecht, the Netherlands., Jin H; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Beijersbergen RL; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Division of Molecular Carcinogenesis, NKI Robotic and Screening Center, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Villanueva A; Chemoresistance and Predictive Factors Group, Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology (ICO), Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet del Llobregat, Barcelona, Spain.; Xenopat S.L., Parc Cientific de Barcelona (PCB), Barcelona, Spain., Medema RH; Division of Cell Biology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Bernards R; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands.

المصدر: Cancer discovery [Cancer Discov] 2024 Jul 01; Vol. 14 (7), pp. 1276-1301.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE

مواضيع طبية MeSH: Signal Transduction* , Protein Phosphatase 2*/metabolism , Colonic Neoplasms*/drug therapy , Colonic Neoplasms*/metabolism , Colonic Neoplasms*/pathology , Colonic Neoplasms*/genetics, Humans ; Animals ; Mice ; Cell Line, Tumor ; Xenograft Model Antitumor Assays ; Cell Cycle Proteins/metabolism ; Cell Cycle Proteins/antagonists & inhibitors ; Protein-Tyrosine Kinases/antagonists & inhibitors ; Protein-Tyrosine Kinases/metabolism ; Drug Resistance, Neoplasm ; Nuclear Proteins/metabolism ; Nuclear Proteins/genetics ; DNA Replication

المؤلفون: Clark MC; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Medical Center, Duarte, CA, USA.; Department of Clinical and Translational Project Development, City of Hope Medical Center, Duarte, CA, USA., Lu RO; Department of Neurological Surgery, University of California, San Francisco, CA, USA.; Helen Diller Comprehensive Cancer Center, University of California, San Francisco, CA, USA., Ho WS; Department of Neurological Surgery, University of California, San Francisco, CA, USA., Dias MH; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Bernards R; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Forman SJ; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Medical Center, Duarte, CA, USA.

المصدر: Molecular oncology [Mol Oncol] 2024 Jun 26. Date of Electronic Publication: 2024 Jun 26.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE

المؤلفون: Dias MH; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Papagianni C; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Bernards R; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands. Electronic address: r.bernards@nki.nl.

المصدر: Cancer cell [Cancer Cell] 2024 Jun 10; Vol. 42 (6), pp. 919-922. Date of Electronic Publication: 2024 May 23.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasms*/drug therapy , Neoplasms*/genetics , Neoplasms*/metabolism , Signal Transduction*/drug effects, Humans ; Antineoplastic Agents/pharmacology ; Antineoplastic Agents/therapeutic use ; Animals ; Oncogenes ; Molecular Targeted Therapy/methods

المؤلفون: Dias MH; Division of Molecular Carcinogenesis and Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Liudkovska V; IMol Polish Academy of Sciences, Warsaw, Poland., Montenegro Navarro J; Division of Oncogenomics and Oncode institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Giebel L; Division of Oncogenomics and Oncode institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Champagne J; Division of Oncogenomics and Oncode institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Papagianni C; Division of Molecular Carcinogenesis and Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Bleijerveld OB; Proteomics Facility, Netherlands Cancer Institute, Amsterdam, Netherlands., Velds A; Central Genomics Facility, Netherlands Cancer Institute, Amsterdam, Netherlands., Agami R; Division of Oncogenomics and Oncode institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Bernards R; Division of Molecular Carcinogenesis and Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands. r.bernards@nki.nl., Cieśla M; IMol Polish Academy of Sciences, Warsaw, Poland. m.ciesla@imol.institute.

المصدر: EMBO reports [EMBO Rep] 2024 May; Vol. 25 (5), pp. 2220-2238. Date of Electronic Publication: 2024 Apr 10.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 100963049 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1469-3178 (Electronic) Linking ISSN: 1469221X NLM ISO Abbreviation: EMBO Rep Subsets: MEDLINE

مواضيع طبية MeSH: Colonic Neoplasms*/genetics , Colonic Neoplasms*/immunology , Colonic Neoplasms*/drug therapy , Colonic Neoplasms*/metabolism , RNA Splicing*/drug effects, Humans ; Alternative Splicing/drug effects ; Antigens, Neoplasm/metabolism ; Antigens, Neoplasm/genetics ; Antigens, Neoplasm/immunology ; Cell Line, Tumor ; Enzyme Inhibitors/pharmacology ; Phosphorylation ; Protein Phosphatase 2/metabolism ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; Serine-Arginine Splicing Factors/metabolism ; Serine-Arginine Splicing Factors/genetics ; Piperazines/pharmacology

المؤلفون: Jansen RA; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam 1066 CX, The Netherlands., Mainardi S; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam 1066 CX, The Netherlands., Dias MH; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam 1066 CX, The Netherlands., Bosma A; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam 1066 CX, The Netherlands., van Dijk E; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam 1066 CX, The Netherlands., Selig R; HepaRegeniX GmbH, Tuebingen 72072, Germany., Albrecht W; HepaRegeniX GmbH, Tuebingen 72072, Germany., Laufer SA; Department of Pharmaceutical and Medicinal Chemistry, Institute of Pharmaceutical Sciences, Eberhard Karls Universität Tübingen, Tübingen 72074, Germany.; Tübingen Center for Academic Drug Discovery and Development, Tübingen 72074, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies' (EXC 2180), Eberhard Karls Universität Tübingen, Tübingen 72076, Germany., Zender L; Tübingen Center for Academic Drug Discovery and Development, Tübingen 72074, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies' (EXC 2180), Eberhard Karls Universität Tübingen, Tübingen 72076, Germany.; Department of Medical Oncology and Pneumology, University Hospital Tübingen, Tübingen 72076, Germany.; German Cancer Research Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg 69120, Germany., Bernards R; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam 1066 CX, The Netherlands.

المصدر: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2024 Feb 27; Vol. 121 (9), pp. e2319492121. Date of Electronic Publication: 2024 Feb 20.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1091-6490 (Electronic) Linking ISSN: 00278424 NLM ISO Abbreviation: Proc Natl Acad Sci U S A Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents*/pharmacology , Colonic Neoplasms*/drug therapy , Colonic Neoplasms*/genetics , Lung Neoplasms*/drug therapy , Lung Neoplasms*/genetics, Humans ; Animals ; Mice ; Proto-Oncogene Proteins p21(ras)/genetics ; Precision Medicine ; Oncogenes ; Mutation ; MAP Kinase Kinase 4

المؤلفون: Kasaeva T; Global Tuberculosis Programme, WHO, Geneva, Switzerland., Kanchar A; Global Tuberculosis Programme, WHO, Geneva, Switzerland., Dias MH; Global Tuberculosis Programme, WHO, Geneva, Switzerland., Falzon D; Global Tuberculosis Programme, WHO, Geneva, Switzerland., Zignol M; Global Tuberculosis Programme, WHO, Geneva, Switzerland., Pablos-Mendez A; Division of General Medicine, Columbia University Medical Center, New York, NY, USA.

المصدر: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease [Int J Tuberc Lung Dis] 2021 Sep 01; Vol. 25 (9), pp. 693-695.

نوع المنشور: Editorial

بيانات الدورية: Publisher: The Union Country of Publication: France NLM ID: 9706389 Publication Model: Print Cited Medium: Internet ISSN: 1815-7920 (Electronic) Linking ISSN: 10273719 NLM ISO Abbreviation: Int J Tuberc Lung Dis Subsets: MEDLINE

مواضيع طبية MeSH: Antibiotic Prophylaxis* , Antitubercular Agents*/therapeutic use , Tuberculosis*/prevention & control, Humans

المؤلفون: Dias MH; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Bernards R; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

المصدر: Molecular oncology [Mol Oncol] 2021 Aug; Vol. 15 (8), pp. 1975-1985. Date of Electronic Publication: 2021 May 26.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Signal Transduction*, Mitogens/*metabolism , Neoplasms/*pathology, Cell Proliferation ; Drug Resistance, Neoplasm ; Homeostasis ; Humans ; Neoplasms/metabolism ; Tumor Microenvironment

المؤلفون: Jin H; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Shi Y; Department of Interventional Oncology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Lv Y; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Yuan S; The Third Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Shanghai, China., Ramirez CFA; Division of Tumour Biology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Lieftink C; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Wang L; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Wang S; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Wang C; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Dias MH; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Jochems F; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Yang Y; The Third Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Shanghai, China., Bosma A; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Hijmans EM; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., de Groot MHP; Division of Tumour Biology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Vegna S; Division of Tumour Biology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Cui D; Department of Interventional Oncology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Zhou Y; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Ling J; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Wang H; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Guo Y; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Zheng X; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Isima N; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Wu H; Department of Cell and Chemical Biology, Leiden University Medical Centre, Leiden, The Netherlands., Sun C; Division of Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Immune Regulation in Cancer Group, German Cancer Research Center, Heidelberg, Germany., Beijersbergen RL; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Akkari L; Division of Tumour Biology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Zhou W; The Third Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Shanghai, China. ehphwp@126.com., Zhai B; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. zhaiboshi@sina.com.; Department of Interventional Oncology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. zhaiboshi@sina.com., Qin W; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. wxqin@sjtu.edu.cn., Bernards R; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands. r.bernards@nki.nl.

المصدر: Nature [Nature] 2021 Jul; Vol. 595 (7869), pp. 730-734. Date of Electronic Publication: 2021 Jul 21.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*pharmacology , Carcinoma, Hepatocellular/*metabolism , Liver Neoplasms/*metabolism , Phenylurea Compounds/*pharmacology , Quinolines/*pharmacology, Animals ; Carcinoma, Hepatocellular/drug therapy ; Cell Line, Tumor ; Drug Resistance, Neoplasm ; ErbB Receptors/antagonists & inhibitors ; ErbB Receptors/metabolism ; Female ; Gefitinib/pharmacology ; Humans ; Liver Neoplasms/drug therapy ; Male ; Mice ; Mice, Inbred BALB C ; Mice, Nude ; Receptors, Fibroblast Growth Factor ; Signal Transduction ; Xenograft Model Antitumor Assays

المؤلفون: Cararo-Lopes E; Center of Toxins, Immune-response and Cell Signaling, Instituto Butantan, SãoPaulo, SP, 05503-900, Brazil. edu.llopes@gmail.com.; Department of Biochemistry, Instituto de Química, Universidade de São Paulo, São Paulo, SP, 05508-000, Brazil. edu.llopes@gmail.com.; Department of Chemical and Biological Sciences, Instituto de Biociência, Universidade do Estado de São Paulo, Botucatu, SP, 18618-689, Brazil. edu.llopes@gmail.com., Dias MH; Department of Biochemistry, Instituto de Química, Universidade de São Paulo, São Paulo, SP, 05508-000, Brazil., da Silva MS; Department of Biochemistry, Instituto de Química, Universidade de São Paulo, São Paulo, SP, 05508-000, Brazil.; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, 08901, USA., Zeidler JD; Department of Biochemistry, Instituto de Química, Universidade de São Paulo, São Paulo, SP, 05508-000, Brazil.; Department of Medicine, Washington University in St. Louis, St. Louis, MO, 63110, USA., Vessoni AT; Department of Microbiology, Instituto de Biociências, Universidade de São Paulo, São Paulo, SP, 05508-900, Brazil., Reis MS; Department of Biochemistry, Instituto de Química, Universidade de São Paulo, São Paulo, SP, 05508-000, Brazil., Boccardo E; Kogod Aging Center, Department of Anesthesiology and Perioperative Medicine, Mayo Clinic College of Medicine, Rochester, MN, 55905, USA., Armelin HA; Department of Biochemistry, Instituto de Química, Universidade de São Paulo, São Paulo, SP, 05508-000, Brazil. haarmelin@iq.usp.br.; Department of Chemical and Biological Sciences, Instituto de Biociência, Universidade do Estado de São Paulo, Botucatu, SP, 18618-689, Brazil. haarmelin@iq.usp.br.

المصدر: Cell death & disease [Cell Death Dis] 2021 Mar 17; Vol. 12 (4), pp. 293. Date of Electronic Publication: 2021 Mar 17.

نوع المنشور: Published Erratum

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101524092 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-4889 (Electronic) NLM ISO Abbreviation: Cell Death Dis Subsets: PubMed not MEDLINE; MEDLINE

المؤلفون: De Conti G; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., Dias MH; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., Bernards R; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.

المصدر: Cancers [Cancers (Basel)] 2021 Mar 05; Vol. 13 (5). Date of Electronic Publication: 2021 Mar 05.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE